PlainPharmaWatch

CMS Open Payments · Program Year 2024

Fresenius USA Marketing, Inc.

Fresenius USA Marketing, Inc. reported $1,560,493.71 in payments to 10,547 physicians and teaching hospitals across 10,583 transactions.

See the rankings → How this is sourced
$1.6M
Total payments
10,583
Transactions
10,547
Recipients
−$39.0K
General Payments vs PY2023

Fresenius USA Marketing, Inc. reported $1,560,493.71 in payments to 10,547 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #515 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $147.96 per recipient across 5 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Fresenius USA Marketing, Inc. pairs above-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#515
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
5
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Fresenius USA Marketing, Inc.'s CMS-reported General Payments decreased by $39.0K (−5.2%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: FRESENIUS USA MARKETING, INC.PY2023: FRESENIUS USA MARKETING, INC.PY2024: Fresenius USA Marketing, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$748.1KPY2024$709.1K
PY2023
$748,124.01
PY2024
$709,099.63

How Fresenius USA Marketing, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Fresenius USA Marketing, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,560,494 Top 27% higher than 73% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Fresenius USA Marketing, Inc.

$1,560,493.71: that is what Fresenius USA Marketing, Inc. reported in payments to 10,547 physicians and teaching hospitals during Program Year 2024, spread across 10,583 transactions ($147.45 per transaction, $147.96 per recipient). The company sits at rank #515 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 5 general-payment categories charted below, "Food and Beverage" is the largest at $243.3K across 9,921 transactions, 15.6% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Fresenius USA Marketing, Inc. made 5 types of general payments. "Food and Beverage" is the largest category at $243.3K, 15.6% of the company's reported total.

How Fresenius USA Marketing, Inc. divides its payments

Ranked by total dollars reported per category

1. Food and Beverage$243.3K2. Honoraria$219.4K3. Travel and Lodging$122.9K4. Consulting Fee$75.8K5. Compensation for Faculty …$47.7K
Payment Type Amount Transactions
Food and Beverage $243.3K 9,921
Honoraria $219.4K 148
Travel and Lodging $122.9K 415
Consulting Fee $75.8K 36
Compensation for Faculty or Speaker (Medical Education) $47.7K 27

Recipient Concentration in General Payments

The five largest recipient relationships account for $157,387.72 (22.2%) of $709,099.63 in this company's General Payments records across 3,498 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Fresenius USA Marketing, Inc.

The five named recipients with the highest reported General Payments from this company

Flavius Nascimento$52.1KLuis Alvarez$33.8KPrecious J Hodges$26.0KJoseph Olawole Ogunsulire$24.3KAnjay Rastogi$21.2K
  1. 1

    Flavius Nascimento

    $52,086.45 across 106 reported transactions

  2. 2

    Luis Alvarez

    $33,814.23 across 71 reported transactions

  3. 3

    Precious J Hodges

    $25,993.14 across 70 reported transactions

  4. 4

    Joseph Olawole Ogunsulire

    $24,325.36 across 71 reported transactions

  5. 5

    Anjay Rastogi

    $21,168.54 across 46 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $147.45. Average per recipient: $147.96.

Total Amount

$1,560,493.71

Avg per Transaction

$147.45

Avg per Recipient

$147.96

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Fresenius USA Marketing, Inc. Share

0.0%

#515 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Fresenius USA Marketing, Inc.

Myriad Genetic Laboratories, Inc.

$1.6M 11,970 recipients

Zevra Therapeutics Inc

$1.5M 25 recipients

Krystal Biotech Inc

$1.6M 1,118 recipients

Integrity Implants Inc. dba Accelus

$1.6M 1,045 recipients

Instylla, Inc.

$1.5M 124 recipients

Balt USA, LLC

$1.5M 1,737 recipients

Frequently Asked Questions

How much did Fresenius USA Marketing, Inc. pay to physicians and hospitals in 2024? ▾
Fresenius USA Marketing, Inc. made $1,560,493.71 in payments to physicians and hospitals in Program Year 2024, across 10,583 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Fresenius USA Marketing, Inc.? ▾
10,547 physicians and teaching hospitals received payments from Fresenius USA Marketing, Inc. in 2024, averaging $147.96 per recipient.
What types of payments did Fresenius USA Marketing, Inc. make? ▾
General payments from Fresenius USA Marketing, Inc. span 5 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Food and Beverage" at $243.3K, representing 15.6% of the company's reported total.
How does Fresenius USA Marketing, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Fresenius USA Marketing, Inc. sits at #515 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Fresenius USA Marketing, Inc.? ▾
In 2024, Fresenius USA Marketing, Inc. averaged $147.45 per transaction across 10,583 transactions to 10,547 recipients.
Where does the payment data for Fresenius USA Marketing, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Fresenius USA Marketing, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.